PDF(Pubmed)
Abstract：
UNASSIGNED: Tuberculosis (TB) continues to be a common disease in developing countries, among which middle ear TB is rare. Furthermore, it is relatively difficult to make an early diagnosis and provide follow-up treatment for middle ear TB. So, it is necessary to report this case for reference and further discussion.
UNASSIGNED: We reported 1 case of multidrug-resistant tuberculosis otitis media. TB otitis media is rare in tuberculosis; multidrug-resistant TB otitis media is even more rare. Our paper analyzes the possible causes, imaging, molecular biology, pathology, and clinical manifestations of multidrug-resistant TB otitis media.
UNASSIGNED: PCR and DNA molecular biology techniques are highly recommended for the early diagnosis of multidrug-resistant TB otitis media. Early, effective anti-tuberculosis treatment is the guarantee for further recovery for patients with multidrug-resistant TB otitis media.
UNASSIGNED: We reported 1 case of multidrug-resistant tuberculosis otitis media. TB otitis media is rare in tuberculosis; multidrug-resistant TB otitis media is even more rare. Our paper analyzes the possible causes, imaging, molecular biology, pathology, and clinical manifestations of multidrug-resistant TB otitis media.
UNASSIGNED: PCR and DNA molecular biology techniques are highly recommended for the early diagnosis of multidrug-resistant TB otitis media. Early, effective anti-tuberculosis treatment is the guarantee for further recovery for patients with multidrug-resistant TB otitis media.
摘要：
未经批准：结核病（TB）仍然是发展中国家的常见疾病，其中中耳结核病是罕见的。此外，中耳结核的早期诊断和后续治疗相对困难.所以,有必要报告此案例以供参考和进一步讨论。
未经评估：我们报告了1例耐多药结核性中耳炎。结核病中耳炎在结核病中很少见；耐多药结核病中耳炎更为罕见。本文分析了可能的原因,成像,分子生物学,病理学,耐多药结核性中耳炎的临床表现。
未经证实：PCR和DNA分子生物学技术被推荐用于耐多药结核病性中耳炎的早期诊断。早期，有效的抗结核治疗是耐多药结核性中耳炎患者进一步康复的保证。
未经评估：我们报告了1例耐多药结核性中耳炎。结核病中耳炎在结核病中很少见；耐多药结核病中耳炎更为罕见。本文分析了可能的原因,成像,分子生物学,病理学,耐多药结核性中耳炎的临床表现。
未经证实：PCR和DNA分子生物学技术被推荐用于耐多药结核病性中耳炎的早期诊断。早期，有效的抗结核治疗是耐多药结核性中耳炎患者进一步康复的保证。
